Neovasc to Present at JMP Securities Life Sciences Conference
12 June 2017 - 9:00PM
PR Newswire (US)
NASDAQ, TSX: NVCN
VANCOUVER, June 12, 2017 /PRNewswire/ - Neovasc
Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN)
a specialty medical device company today announced that
Alexei Marko, chief executive
officer is scheduled to present at the JMP Securities Life Sciences
Conference being held at the St. Regis Hotel in New York City on Wednesday, June 21, 2017, at 9:30 am ET.
A live audio webcast of the presentation will be available on
the Investors page of Neovasc's website at www.neovasc.com.
About Neovasc Inc.
Neovasc is a specialty medical device company that develops,
manufactures and markets products for the rapidly growing
cardiovascular marketplace. Its products include the Neovasc
Reducer™, for the treatment of refractory angina which is not
currently available in the United
States and has been available in Europe since 2015 and the Tiara™, for the
transcatheter treatment of mitral valve disease, which is currently
under investigation in the United
States, Canada and
Europe. The Company also sells a
line of advanced biological tissue products that are used as key
components in third-party medical products including transcatheter
heart valves. For more information, visit: www.neovasc.com.
SOURCE Neovasc Inc.
Copyright 2017 PR Newswire
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Neovasc (NASDAQ:NVCN)
Historical Stock Chart
From Jul 2023 to Jul 2024